Moneycontrol
Get App
Last Updated : Apr 17, 2019 03:23 PM IST | Source: Moneycontrol.com

Torrent Pharmaceuticals Q4 PAT may dip 12.6% YoY to Rs. 199.3 cr: Kotak

Net Sales are expected to increase by 14.7 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 1,975.8 crore, according to Kotak.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Kotak has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Torrent Pharmaceuticals to report net profit at Rs. 199.3 crore down 12.6% year-on-year (down 19% quarter-on-quarter).


Net Sales are expected to increase by 14.7 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 1,975.8 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 46.7 percent Y-o-Y (down 4.8 percent Q-o-Q) to Rs. 533.9 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Apr 17, 2019 03:23 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant